The institution is optimistic about these stocks today. On December 13th, as of press time, the institution gave 20 latest buy ratings, among which the target price of 9 stocks was announced:-Cobos was optimistic about UBS Securities, giving a target price of 62.00 yuan; -Yingqu Technology was favored by Guotai Junan with a target price of 19.25 yuan; -Yutong Bus, Jinkong Coal Industry, Dong 'e Ejiao and many other stocks are listed.USD/CAD of USD/CAD once rose by 0.2%, hitting a four-and-a-half-year high of 1.4244.Philadelphia SE Semiconductor Index reached its highest level in more than a week, rising by 3.1%.
Morgan Stanley raised the opening target price from $950.00 to $1,150.00.Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).Guangyunda: It is planned to raise no more than 448.9 million yuan from Junguang Investment. Guangyunda announced that the type of shares to be issued by the company to a specific target is domestic listed RMB ordinary shares (A shares) with a par value of RMB 1.00 per share. The object of issue is Shenzhen Junguang Investment Holding Co., Ltd., and the issue price is determined to be 7.74 yuan/share. The number of shares issued this time does not exceed 58 million shares (inclusive), which does not exceed 30% of the total share capital of the company before this issuance. The total amount of funds raised by the proposed stock issue to a specific target does not exceed RMB 448.92 million (inclusive), and the net amount of funds raised after deducting the issuance expenses is intended to be used to supplement the working capital. This proposal still needs to be submitted to the company's shareholders' meeting for consideration.
Minister of Labor of Canada: I asked the Canadian Industrial Relations Committee whether it was determined that the Canadian labor dispute case was deadlocked.Bank of America: Investors poured into China stocks in recent weeks, and Bank of America strategists said that investors put money into China stocks again in the past week. In the week ending Wednesday, China equity funds received about $5.6 billion, the largest inflow in nine weeks, strategists such as Michael Hartnett quoted EPFR Global data as saying. He also believes that the first quarter of next year will be the entry point for non-US stocks. As investors have deployed a large number of positions for the rise in the yield of US dollars and US bonds, there is a risk of overshooting early next year. He believes that bonds, gold and international stocks are attractive under the assumption that persistent inflation forces the Fed to become more hawkish.Jiaying Pharmaceutical Co., Ltd.: The chairman of the board proposed to buy back the company's shares of no more than 132.3 million yuan. On the evening of December 13, Jiaying Pharmaceutical announced that Li Neng, the chairman of the company, proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shenzhen Stock Exchange with its own funds, and the repurchased shares are intended to be used for implementing employee stock ownership plan or equity incentive. According to the proposal, combined with the company's financial operation and actual situation, the number of shares to be repurchased this time is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; It does not exceed 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. According to the calculation that the maximum number of repurchased shares is 13.5 million shares (inclusive) and the maximum price of repurchased shares is 9.80 yuan/share (inclusive), the total amount of repurchased shares does not exceed 132.3 million yuan (inclusive).